Multiple myeloma is a malignant plasma cell disorder occurring mostly in people above 60 years old. The authors describe a case of multiple myeloma in a 36-year-old patient revealed by spinal cord compression and Herpes zoster with a rapidly unfavourable outcome.
Introduction
Multiple myeloma or Kahler's disease is the most common malignant plasma cell disorder characterized by clonal proliferation of malignant plasma cells in the bone marrow, monoclonal protein in serum or urine, associated dysfunction of organs (bone and kidney), anaemia and hypercalcemia [1] . The first detailed description of the disease was made in 1884 by the English physician Solly [2] , who described the case of a 39-year old patient. Multiple myeloma occurs mostly above 60 years, and its incidence increases with age.
The precise cause of myeloma is not known, but many risk factors have been identified notably age, male gender, black skin, exposure to radiations or pesticides, rheumatoid arthritis and obesity [1] . The disease is usually revealed by bone pains, chronic fatigue and fractures of long bones. There is no curative treatment but many drugs can help to prolong survival by 5 to 6 years after the diagnosis [1] . We report a case of multiple myeloma revealed by spinal cord compression and herpes zoster in a 36-year old Cameroonian.
Patient and observation
Verbal informed consent was obtained from the patient's next of kin for publication of this case report.
A 36-year-old female farmer with no relevant past medical history was referred to the neurology department for management of a paraparesis of progressive onset since about 6 months, in a context of fever, weight loss and productive cough. Two weeks prior to the consultation, she had herpes zoster skin lesions of right T4 dermatome. Her physical examination on admission revealed altered general state with weight loss, pallor and fever (38.5°C). There was Four weeks later, a second dose of Melphalan/Prednisone was administered. However, the patient presented with severe anaemia accompanied by fever and dyspnoea and died a day later despite a blood transfusion, which the patient had initially refused.
Discussion
Multiple myeloma is a disease of the elderly, the median age at diagnosis being around 70 years [1, 4] . On a total of 14381 patients diagnosed on a 30-year period, Kristinsson and collaborators found that 80 % of patients were more than 60 years of age and about 1% were aged 40 years or less [3] . Our patient was 36-years old, comparable in age with the first case described in 1888. The cause of the disease is not known, so it is difficult to build up pathophysiological hypothesis for our patient. However, she was found to have several risk factors that could have favoured the development of the disease. She was a black skin farmer who had probably been overexposed to pesticides and other toxic chemical products, which are frequently used for agriculture. Exposure to pesticides is well known as a risk factor for multiple myeloma [1] .
The presentation of the disease in this case is atypical. Rather than the bone pains which are the most common presenting features of myeloma in about 58% of cases [1] , the patient presented with spinal cord compression due to multifocal collapse of the vertebrae. This type of presentation was found in only 0.5% of 646 cases of myeloma recruited by Cheema and collaborators over a period of 17 years [4] . The patient also presented with herpes zoster lesions on admission. Upon literature review, herpes zoster lesions are described as a complication of antimitotic treatment in patients with refractory multiple myeloma [5] , but in our case the patient was not on any specific treatment. Fever is the presenting feature of myeloma in less than 1% of cases [6, 7] . The fever in our patient was probably due to an infection given the context of immune deficiency with herpes zoster lesions on admission, and the improvement of fever on empirical antibiotic treatment.
Nevertheless, we can't exclude myeloma per se as a cause of the fever.
The results of most laboratory tests were similar to those published in the literature for multiple myeloma. The anaemia was normochromic and normocytic and there was no thrombopaenia, which is found in only 10 to 15% of cases [1] . The erythrocyte sedimentation rate was very high in accordance with the abnormal gammaglobulin hypersecretion [8] [9] . However, because it is not accessible in our context, we considered our patient as not a candidate for transplantation and treated her with the association of melphalan and prednisone.
Bisphosphonates reduce osteoclastic bone resorption and thus attenuate bone pains and decrease the risk of pathologic fractures [1, 9] . However this treatment is rare in our setting and was not financially affordable.
Serum beta2-microglobulin (β2M) and albumin levels are the basis for the International Prognostic Index (IPP) which evaluates the prognosis in patients with multiple myeloma [1, 9, 10] . Because of limited finances, the ß2M dosage was not done in our patient.
Nevertheless, given the serum albumin level revealed by protein electrophoresis and the rapidly unfavourable outcome of the illness, our patient was probably at stage III of the disease, which corresponds to a life expectancy of about 29 months. Of newly diagnosed patients, about 39% are found in this stage, while 33% are found in stage II and 28% in stage I [10] .
We could not identify the exact cause of death in our patient.
Taking into consideration the association of fever and severe anaemia, a septic shock is the most probable hypothesis.
